Clinical Trial

Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A

Recruiting Phase 4

Record status

This record was last updated November 5, 2020 (before its estimated January 1, 2021 completion). Its status may not reflect the trial's current state.

Summary

Currently, in clinical practice there has been no standardization in the number of injections a single dose of intradetrusor onabotulinumtoxin A is administered in. Given the increasing use of this treatment modality, the aim of this study is to compare outcomes for patients given a 100 unit dose of onabotulinumtoxin A split into 5 as compared to 20 injections for the treatment of overactive bladder or urgency urinary incontinence refractory to medical treatment.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2020-03-11; most recent amendment 2022-02-19.

Status change: Recruiting → Completed 2022-02-19

Trial Details

NCT Number	NCT04305743
Lead Sponsor	University of South Florida Collaborators: Medstar Health Research Institute
Conditions	Urinary Bladder, Overactive, Incontinence, Urge, Incontinence, Urinary, Urinary Urge Incontinence, Urinary Frequency More Than Once at Night, Nocturia
Enrollment	60 participants
Start Date	2019-10-09
Primary Completion	2021-01-01 (estimated)
Study Completion	2021-06-01 (estimated)
Updated on ClinicalTrials.gov	2020-11-05